Ebola Trending News Powered by Trendolizer

Experimental Ebola vaccines elicit year-long immune response

Trending story found on medicalxpress.com
Experimental Ebola vaccines elicit year-long immune response
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that last for at least one year. The findings, published in the October 12 issue of the New England Journal of Medicine, are based on a study of 1,500 adults that began during the West Africa Ebola outbreak. The trial is being conducted by a U.S.-Liberia clinical research collaboration known as the Partnership for Research on Ebola Virus in Liberia (PREVAIL), established in 2014 in response to the...
[Source: medicalxpress.com] [ Comments ] [See why this is trending]

Trend graph:

Comments